Contribution

Jump to Content

Overview

Our project focuses on developing a lactate-responsive system to remodel the lactate-rich tumor microenvironment, aiming to enhance immune cell-mediated anti-tumor efficacy. Below are the main contributions of our work to the iGEM community, including novel composite parts, validated functional systems, and optimized technological methods.

Key Contributions

  • Novel Composite Parts: Functional lactate sensing and degradation systems
  • Validated Systems: Quantitative performance benchmarks for lactate-responsive circuits
  • Technological Innovations: Optimized protocols and design strategies

First Contribution: Construction of Functional Composite Parts for Lactate Sensing and Degradation

A key achievement of our project is the design and assembly of novel composite parts—cloning multiple basic biological parts (e.g., sequences of lactate-sensing domains, split-TEV fragments, signal peptides) into plasmids. These parts are compatible with mammalian cell systems and can be directly adopted by other teams for studies on lactate metabolism, tumor microenvironment remodeling, or synthetic biology-based responsive therapies.

1.1 Overview

We constructed composite parts using two backbone plasmids: pGL4.35 (for reporter gene expression) and pcDNA3.1(+) (for sensor/sLOx expression). These composite parts fall into three functional categories: (1) Lactate Sensors (LS series), (2) GV-2ER Reporter, and (3) Secreted Lactate Oxidase (sLOx). All parts are designed to work synergistically, forming a complete "sensing-degradation" cascade.

Backbone plasmids

Figure 1: Backbone plasmids used for composite part construction. Left: pGL4.35 (with 9×GAL4 UAS and luciferase reporter); Right: pcDNA3.1 (with CMV promoter for high expression).

1.2 Detailed Basic Parts

The following table summarizes the key basic parts we developed:

Registry Name Short Description Category Part Type
BBa_256TB7H4Signal sequence of rat FSHBSignal PeptideCoding
BBa_K3734014LUCReporter ProteinCoding
BBa_254YC81XTEV-NEnzymeCoding
BBa_25JHHT31TEV-CEnzymeCoding
BBa_25J9Q9U9LOXEnzymeCoding
BBa_25S1N4JOTEV-csProtein_DomainsCoding
BBa_25FSZ80QERT2Protein_DomainsCoding
BBa_25DVCA3AFlagSignal tagCoding
BBa_25MD9GE0GAL4-DBDProtein_DomainsCoding
BBa_25SO4BWDVP64-TADProtein_DomainsCoding
BBa_25M4YZFOLac-sensor-NProtein_DomainsCoding
BBa_25GO4K4QLac-sensor-CProtein_DomainsCoding
BBa_25Z8U6PZLinkerProtein_DomainsCoding
Basic parts overview

Figure 2: The basic parts we used include 13 types such as TEV components, Lac-sensor components, Linker, VP-64TAD, TEV-cs, Flag, and other regulatory elements. These basic parts were utilized to construct our composite parts.

1.3 Detailed Composite Parts

The following table summarizes the key composite parts we developed:

Registry Name Short Description Category Part Type
BBa_25GO5KXNTEV-N+Lac-sensor-NProtein_DomainsCoding
BBa_259DROAJLac-sensor-N+TEV-NProtein_DomainsCoding
BBa_252HRSEXTEV-N+Lac-sensor-CProtein_DomainsCoding
BBa_258UGTVOLac-sensor-C+TEV-NProtein_DomainsCoding
BBa_25VORSOCTEV-C+Lac-sensor-NProtein_DomainsCoding
BBa_25AQ2GTWLac-sensor-N+TEV-CProtein_DomainsCoding
BBa_259BOA6PTEV-C+Lac-sensor-CProtein_DomainsCoding
BBa_253ELPKOLac-sensor-C+TEV-CProtein_DomainsCoding
BBa_25B0LCIOGV2ERProtein_DomainsCoding
BBa_25H9P6QHsLOxProtein_DomainsCoding
BBa_25EPO21ZLS1.0Protein_DomainsCoding
Composite parts design 1

Figure 3: This figure illustrates the design of our composite parts using the uploaded basic parts, which include the lactate-sensing components (LS1.0 and Stev-lac-0.1 to Stev-lac-0.6). These specific composite parts serve as the lactate-sensing module for constructing our system.

Composite parts design 2

Figure 4: This figure illustrates the design of our composite parts using the uploaded basic parts, including partial lactate-sensing components (Stev-lac-0.7 to Stev-lac-0.8), the lactate-degrading component (sLOx), and the regulatory component (GV2ER). Together with the lactate-sensing composite parts shown in the previous figure, these components were used to construct our entire system.

1.4 Key Composite Part Functions

LS3.5 (BBa_252HRSEX)

The most stable and sensitive sensor. In the absence of lactate (0mM), it exhibits minimal background TEV activity (RLU < 20); under 5mM lactate stimulation, TEV activity increases by ~5-fold, enabling precise lactate sensing.

GV2ER (BBa_25B0LCIO)

Converts lactate-induced TEV reconstitution into a transcriptional signal. Active TEV cleaves ERT2 domains, releasing GV to enter the nucleus and activate downstream genes (e.g., sLOx or luciferase).

GV-2ER mechanism

Figure 5: GV-2ER: The "G" stands for the yeast Gal4 DNA-binding domain. In transcriptional regulation, this domain can specifically recognize and bind to DNA sequences containing Gal4 response elements. The "V" represents the herpes simplex virus VP64 transactivation domain, which possesses a potent function of activating transcription.

sLOx (BBa_25H9P6QH)

The rat FSHB signal peptide directs sLOx secretion into the extracellular space, where it catalyzes lactate oxidation to pyruvate and H₂O₂. Western blot confirms sLOx presence in cell culture medium.

sLOx plasmid map

Figure 6: This figure presents the map of the novel plasmid designed for verifying sLOx function. On the basis of the original plasmid used in sensor screening (which contained the Luciferase reporter gene), the Luciferase gene was replaced with the optimized sLOx gene. The plasmid retains key elements required for gene expression and cell screening, enabling the expression of sLOx to be regulated by the upstream lactate sensor system and facilitating subsequent verification of sLOx secretion and lactate-degrading activity.

Second Contribution: Functional Validation of the Lactate-Responsive System

These validation data provide a benchmark for other teams working on lactate-related systems.

We validated our lactate-responsive system through quantitative experiments, ensuring its reliability and providing a benchmark for others in the field.

2.1 Validation of Lactate Sensor Performance

We conducted two rounds of screening and validation for LS series sensors using a dual-luciferase reporter assay (pGL4.35 as the luciferase vector):

Background Screening

Among 8 LS3.x variants (LS3.1–LS3.8), LS3.5, LS3.6, and LS3.8 showed the lowest background TEV activity (RLU < 30) in the absence of lactate.

Background screening results

Figure 7: This figure presents the background screening results of the LS3.1-LS3.8 sensors. The ordinate (RLU) reflects the TEV enzyme activity of each sensor without lactate stimulation; the results help screen out sensors with low background activity (e.g., LS3.5, LS3.6, LS3.8).

Sensitivity & Stability

LS3.5 exhibited the most significant dose-dependent response:

  • 0mM lactate: RLU = 18 ± 3
  • 1mM lactate: RLU = 42 ± 5
  • 5mM lactate: RLU = 95 ± 8

This confirms LS3.5's ability to distinguish physiological lactate concentrations.

Sensitivity validation results

Figure 8: This figure shows the sensitivity and stability verification results of the screened low-background sensors (LS3.5, LS3.6, LS3.8) under different lactate concentrations (0mM, 1mM, 5mM). The ordinate (RLU) indicates TEV enzyme activity; the results confirm that LS3.5 has the highest sensitivity and stability, as it shows a more obvious response to lactate concentration changes while maintaining low background.

2.2 Validation of sLOx Secretion and Lactate Degradation

To confirm sLOx's function in extracellular lactate degradation:

Secretion Validation

Western blot analysis of cell lysates and culture medium showed sLOx bands exclusively in the medium of LS3.5-transfected 293T cells (no bands in negative control (NC) medium).

Western blot results

Figure 9: This figure displays the results of the Western blot assay used to verify sLOx protein secretion. The blot includes two sample types: culture medium (extracellular fluid) and cell lysate (intracellular fluid), with both NC (negative control) and LS3.5 (sensor-sLOx system) groups tested. The presence of the sLOx protein band in the culture medium of the LS3.5 group (while no obvious band is detected in the NC group's culture medium) confirms that the engineered sLOx protein was successfully secreted from 293T cells into the extracellular space.

Degradation Efficacy

Using the WST-8 lactate assay, we found that the extracellular lactate concentration in the LS3.5 group was ~60% lower than that in the NC group, demonstrating sLOx's efficient lactate-degrading activity.

Lactate degradation results

Figure 10: This figure shows the results of the extracellular lactate degradation assay. The ordinate represents the relative concentration of extracellular lactate, and the abscissa shows the NC group and the LS3.5 group (sensor-sLOx system group). The results clearly indicate that compared with the NC group, the extracellular lactate concentration in the LS3.5 group is significantly lower, directly demonstrating that the secreted sLOx protein has a stable and efficient lactate-degrading function, which can reduce the local extracellular lactate concentration as expected.

Third Contribution: Technological Innovations and Method Optimization

We addressed key technical challenges in lactate-responsive system design and established standardized experimental protocols, which can be adopted by other iGEM teams to accelerate their research.

3.1 Split-TEV-LldR Fusion Design to Reduce Background Activity

Challenge Addressed

A major challenge in initial sensor design (LS1.0, LS2.0) was high background TEV activity (RLU > 600 without lactate).

Our Innovation

We innovated by:

  • Splitting LldR into Lac-N and Lac-C fragments (instead of using full-length LldR)
  • Testing 8 different fusion combinations of Lac-N/C and TEV-N/C (LS3.1–LS3.8)
  • This design reduced the spatial proximity of TEV fragments in the absence of lactate, lowering background activity to RLU < 30 (LS3.5)

3.2 Standardized Protocols for Lactate-Related Experiments

We optimized and documented step-by-step protocols for:

Available Protocols

  • Dual-Luciferase Reporter Assay: For sensor activity quantification (details in Experimental Wiki Section 3.2.2)
  • WST-8 Lactate Assay: For extracellular lactate concentration measurement (details in Experimental Wiki Section 3.4.3)
  • sLOx Western Blot: For validating protein secretion (details in Experimental Wiki Section 3.3.2)

These protocols are reproducible and have been tested in 293T cells, providing a reliable framework for other teams.

References

  1. Wintgens JP, Wichert SP, Popovic L, et al. Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays. Cell Mol Life Sci. 2019;76(6):1185–1199. doi:10.1007/s00018-018-03003-2
  2. Li X, Zhang Y, Xu L, et al. Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease. Cell Metab. 2023;35(1):200–211.e9. doi:10.1016/j.cmet.2022.10.002
  3. Glancy B, Kane DA, Kavazis AN, et al. Mitochondrial lactate metabolism: history and implications for exercise and disease. J Physiol. 2021;599(3):863–888. doi:10.1113/JP278930
  4. Liu H, Liu Y, Liu S, et al. Simultaneous Monitoring of Intracellular Glucose and Extracellular Lactate in Single Cells to Assess Cell Tumorigenicity. Anal Chem. 2025. doi:10.1021/acs.analchem.5c03740